Hyperbaric oxygen upregulates cochlear constitutive nitric oxide synthase.
BMC Neurosci
; 12: 21, 2011 Feb 22.
Article
em En
| MEDLINE
| ID: mdl-21342510
ABSTRACT
BACKGROUND:
Hyperbaric oxygen therapy (HBOT) is a known adjuvant for treating ischemia-related inner ear diseases. Controversies still exist in the role of HBOT in cochlear diseases. Few studies to date have investigated the cellular changes that occur in inner ears after HBOT. Nitric oxide, which is synthesized by nitric oxide synthase (NOS), is an important signaling molecule in cochlear physiology and pathology. Here we investigated the effects of hyperbaric oxygen on eardrum morphology, cochlear function and expression of NOS isoforms in cochlear substructures after repetitive HBOT in guinea pigs.RESULTS:
Minor changes in the eardrum were observed after repetitive HBOT, which did not result in a significant hearing threshold shift by tone burst auditory brainstem responses. A differential effect of HBOT on the expression of NOS isoforms was identified. Upregulation of constitutive NOS (nNOS and eNOS) was found in the substructures of the cochlea after HBOT, but inducible NOS was not found in normal or HBOT animals, as shown by immunohistochemistry. There was no obvious DNA fragmentation present in this HBOT animal model.CONCLUSIONS:
The present evidence indicates that the customary HBOT protocol may increase constitutive NOS expression but such upregulation did not cause cell death in the treated cochlea. The cochlear morphology and auditory function are consequently not changed through the protocol.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Regulação para Cima
/
Cóclea
/
Óxido Nítrico Sintase Tipo I
/
Óxido Nítrico Sintase Tipo III
/
Oxigenoterapia Hiperbárica
Tipo de estudo:
Guideline
Limite:
Animals
Idioma:
En
Ano de publicação:
2011
Tipo de documento:
Article